  See all
 |
Articles: Leukemia/Lymphoma |
Prior Articles
The Novel Tubulin-Targeting Agent Pyrrolo-1,5-Benzoxazepine-15 Induces Apoptosis in Poor Prognostic Subgroups of Chronic Lymphocytic Leukemia
Cancer Research, 11/02/09
Nilotinib for the frontline treatment of Ph+ chronic myeloid leukemia
Blood, 10/30/09 MACOP-B regimen in the treatment of adult Langerhans cell histiocytosis: experience on seven patients
Annals of Oncology, 10/30/09 Clinical outcome in patients with small intestinal non-Hodgkin lymphoma
Leukemia and Lymphoma, 10/30/09 Patients with del(5q) MDS who fail to achieve sustained erythroid or cytogenetic remission after treatment with lenalidomide have an increased risk for clonal evolution and AML progression
Annals of Hematology, 10/30/09 p53 expression by immunohistochemistry is an important determinant of survival in patients with chronic lymphocytic leukemia receiving frontline chemo-immunotherapy
Leukemia and Lymphoma, 10/30/09 Plerixafor inhibits chemotaxis toward SDF-1 and CXCR4-mediated stroma contact in a dose-dependent manner resulting in increased susceptibility of BCR-ABL + cell to Imatinib and Nilotinib
Leukemia and Lymphoma, 10/30/09 Expression level, tissue distribution pattern, and prognostic impact of vascular endothelial growth factors VEGF and VEGF-C and their receptors Flt-1, KDR, and Flt-4 in different subtypes of non-Hodgkin lymphomas
Leukemia and Lymphoma, 10/30/09 High rate of survival in transformed lymphoma after autologous stem cell transplant: pathologic analysis and comparison with de novo diffuse large B-cell lymphoma
Leukemia and Lymphoma, 10/30/09 Protein kinase C-beta II expression in diffuse large B-cell lymphoma predicts for inferior outcome of anthracycline-based chemotherapy with and without rituximab
Leukemia and Lymphoma, 10/30/09 A prospective study of left ventricle function after treatment with rapid-infusion Rituximab in patients with non-Hodgkin lymphoma
Leukemia and Lymphoma, 10/30/09 Radiation therapy compared with chemotherapy for consolidation of chemotherapy-induced remission of advanced Hodgkin lymphoma: a study by the Eastern Co-operative Oncology Group (E1476) with >20 years follow-up
Leukemia and Lymphoma, 10/30/09 Recombinant interferon-alpha2b added to oral cyclophosphamide either as induction or maintenance in treatment-naive follicular lymphoma: final analysis of CALGB 8691
Leukemia and Lymphoma, 10/30/09 Functional signatures identified in B-cell non-Hodgkin lymphoma profiles
Leukemia and Lymphoma, 10/30/09 Influence of the polymorphism in candidate genes on late cardiac damage in patients treated due to acute leukemia in childhood
Leukemia and Lymphoma, 10/30/09 T-box-expressed-in-T-cells (T-bet) expression by the tumor cells of hairy cell leukemia correlates with interferon-gamma production
Leukemia and Lymphoma, 10/30/09 Do male lymphoma survivors have impaired sexual function?
Journal of Clinical Oncology, 10/29/09 VMP (bortezomib, melphalan, and prednisone) is active and well tolerated in newly diagnosed patients with multiple myeloma with moderately impaired renal function, and results in reversal of renal impairment: Cohort analysis of the phase III Vista study
Journal of Clinical Oncology, 10/29/09 Management of relapse after allo-SCT for AML and the role of second transplantation
Bone Marrow Transplantation, 10/29/09
Exclusive Author Commentary High dose intensity doxorubicin in aggressive non-Hodgkin's lymphoma: a literature-based meta-analysis
Annals of Oncology, 10/29/09
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: Journal of Clinical Oncology, Cancer Research, Annals Oncology
more...
|
250 Available Pages
|
|
